| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.0064 |
0.9 |